Cargando…
Assessment of Anti-tumor Efficacy of Osimertinib in Non–Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion
PURPOSE: This study was to evaluate anti-tumor efficacy of osimertinib in patients positive for acquired epidermal growth factor receptor (EGFR) T790M mutation in liquid biopsy using plasma, bronchoalveolar lavage fluid (BALF) or bronchial washing fluid (BWF), and pleural effusion. MATERIALS AND MET...
Autores principales: | Kim, Yeon Joo, Ji, Won Jun, Lee, Jae-Cheol, Chun, Sung-Min, Choi, Chang-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582461/ https://www.ncbi.nlm.nih.gov/pubmed/35038824 http://dx.doi.org/10.4143/crt.2021.857 |
Ejemplares similares
-
Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions
por: Sorolla, Maria Alba, et al.
Publicado: (2021) -
Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC
por: Kim, In Ae, et al.
Publicado: (2022) -
EV-based EGFR genotyping in bronchoalveolar lavage fluid—a step forward from blood?
por: Ji, Wonjun, et al.
Publicado: (2020) -
Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice
por: Cruickshank-Quinn, Charmion, et al.
Publicado: (2017) -
Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers
por: Wu, Huita, et al.
Publicado: (2022)